Neuropathological autopsy findings after CD19 CAR-T-cell therapy for diffuse large B-cell lymphoma

被引：0
|
作者：
Champion, Samantha [1 ]
Martinez-Lage, Maria [1 ]
机构：
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1630
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma
    Albanyan, Omar
    Chavez, Julio
    Munoz, Javier
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [42] The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma
    Albanyan, Omar
    Chavez, Julio
    Munoz, Javier
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [43] Long-term follow-up of humanized and murine CD19 CAR-T-cell therapy for B-cell acute lymphoblastic leukemia
    都孟仪
    China Medical Abstracts(Internal Medicine), 2024, 41 (01) : 59 - 60
  • [44] Improved outcomes of large B-cell lymphoma patients treated with CD19 CAR T in the UK over time
    Boyle, S.
    Roddie, C.
    O'Reilly, M.
    Menne, T.
    Norman, J.
    Gibb, A.
    Lugthart, S.
    Chaganti, S.
    Arias, C. Gonzalez
    Jones, C.
    Latif, A.
    Uttenthal, B. J.
    Seymour, F.
    Osborne, W.
    Springell, D.
    Hardefeldt, P.
    Yallop, D.
    Thoulouli, E.
    Bloor, A.
    Besley, C.
    Mathew, A.
    Burns, D.
    Cwynarski, K.
    Sanderson, R.
    Kuhnl, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (02) : 507 - 513
  • [45] The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy
    Jain, Michael D.
    Faramand, Rawan
    Staedtke, Verena
    Bai, Renyuan
    Lee, Sae Bom
    Kotani, Hiroshi
    Reid, Kayla
    Spitler, Kristen
    Chavez, Julio
    Shah, Bijal
    Bachmeier, Christina A.
    Dam, Marian
    Brandjes, Brigett
    Gonzalez, Ricardo J.
    Mullinax, John E.
    Wang, Xuefeng
    Hussaini, Mohammad
    Locke, Frederick L.
    Davila, Marco L.
    BLOOD, 2019, 134
  • [46] Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK
    Kuhnl, A.
    Roddie, C.
    Kirkwood, A. A.
    Chaganti, S.
    Norman, J.
    Lugthart, S.
    Osborne, W.
    Gibb, A.
    Gonzalez Arias, C.
    Latif, A.
    Uttenthal, B.
    Seymour, F.
    Jones, C.
    Springell, D.
    Brady, J. L.
    Illidge, T.
    Stevens, A.
    Alexander, E.
    Hawley, L.
    O'Rourke, N.
    Bedi, C.
    Prestwich, R.
    Frew, J.
    Burns, D.
    O'Reilly, M.
    Sanderson, R.
    Sivabalasingham, S.
    Mikhaeel, N. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (02) : 483 - 494
  • [47] Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
    Wudhikarn, Kitsada
    Palomba, M. Lia
    Pennisi, Martina
    Garcia-Recio, Marta
    Flynn, Jessica R.
    Devlin, Sean M.
    Afuye, Aishat
    Silverberg, Mari Lynne
    Maloy, Molly A.
    Shah, Gunjan L.
    Scordo, Michael
    Dahi, Parastoo B.
    Sauter, Craig S.
    Batlevi, Connie L.
    Santomasso, Bianca D.
    Mead, Elena
    Seo, Susan K.
    Perales, Miguel-Angel
    BLOOD CANCER JOURNAL, 2020, 10 (08)
  • [48] Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma
    Kitsada Wudhikarn
    M. Lia Palomba
    Martina Pennisi
    Marta Garcia-Recio
    Jessica R. Flynn
    Sean M. Devlin
    Aishat Afuye
    Mari Lynne Silverberg
    Molly A. Maloy
    Gunjan L. Shah
    Michael Scordo
    Parastoo B. Dahi
    Craig S. Sauter
    Connie L. Batlevi
    Bianca D. Santomasso
    Elena Mead
    Susan K. Seo
    Miguel-Angel Perales
    Blood Cancer Journal, 10
  • [49] Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma
    Chow, Victor A.
    Shadman, Mazyar
    Gopal, Ajay K.
    BLOOD, 2018, 132 (08) : 777 - 781
  • [50] Clinical phenotypes of CAR-T-cell related hematotoxicity in relapsed/refractory large B-cell lymphoma
    Rejeski, K.
    Sesques, P.
    Berger, C.
    Jentzsch, L.
    Mougiakakos, D.
    Froelich, L.
    Bucklein, V
    Blumenberg, V
    Schmidt, C.
    Jallades, L.
    Fehse, B.
    Faul, C.
    Weigert, O.
    Dreyling, M.
    von Bergwelt-Baildon, M.
    Mackensen, A.
    Bethge, W.
    Ayuk, F.
    Bachy, E.
    Salles, G.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 45 - 46
12345